BackChina Botanic Pharmaceutical Overview

China Botanic Pharmaceutical Operating Income

Track China Botanic Pharmaceutical's operating income ($-140K) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow

Quarterly Operating Income

$-20141.00
↓ 55.33% YoY

As of Jul 31, 2025

Annual Operating Income (TTM)

$-143644.00
↓ 94.98% YoY

Trailing 12 months ending Jul 31, 2025

Average Operating Income (Comparison Companies)

Operating Income History

Operating Income Comparison

Annual Operating Income Growth Rate (%)

Annual Operating Income Growth (Absolute)

China Botanic Pharmaceutical (CBPI) FAQ

China Botanic Pharmaceutical (CBPI) currently reports a operating income of $-140K as of July 2025. That compares with $-2.9M in the prior-year period — up 95.0% year over year. Use the charts on this page to explore China Botanic Pharmaceutical's operating income history and peer comparisons.

China Botanic Pharmaceutical's operating income increased from $-2.9M to $-140K — a 95.0% year-over-year increase (period ending July 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

China Botanic Pharmaceutical reported $-140K in operating income as of July 2025. That compares with $-2.9M in the prior-year period — up 95.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current operating income of $-140K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for China Botanic Pharmaceutical, and consider following CBPI for alerts when major investors trade the stock.